United States · FDA National Drug Code directory
Diltiazem Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50228-481_31a9f85e-b3f0-4b39-a133-8d4324df2aff
- Product NDC
- 50228-481
- Form
- TABLET
- Composition / generic term
- Diltiazem hydrochloride
- Labeler
- ScieGen Pharmaceuticals, Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220926
- Source listing expiry
- 20261231
Source-listed ingredients
- DILTIAZEM HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (50228-481-01) · 50228-481-01
- 500 TABLET in 1 BOTTLE (50228-481-05) · 50228-481-05
- 1000 TABLET in 1 BOTTLE (50228-481-10) · 50228-481-10
- 30 TABLET in 1 BOTTLE (50228-481-30) · 50228-481-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →